Adiponectin Attenuates Cognitive Impairment After Splenectomy in Aged Rats: Mechanistic and Translational Insights

Study Background and Research Question

Perioperative neurocognitive disorder (PND) is a major complication following surgery, especially in elderly patients, affecting cognitive domains such as memory, attention, and executive function. The pathogenesis of PND remains incompletely understood, but mounting evidence implicates neuroinflammation and oxidative stress as central contributors. Adiponectin, a plasma protein secreted by adipose tissue, has been associated with neuroprotection in several contexts, but its role in PND following peripheral trauma had not been mechanistically elucidated. The reference study investigates whether adiponectin administration can mitigate splenectomy-induced cognitive deficits in aged rats and explores the underlying signaling pathways involved.

Key Innovation from the Reference Study

The principal innovation of this study is the identification of adiponectin’s neuroprotective effects in the context of surgically induced cognitive impairment in aged rats. Specifically, the research demonstrates that adiponectin pretreatment attenuates memory and learning deficits by modulating the TLR4/MyD88/NF-κB signaling axis, thereby reducing neuroinflammatory and oxidative responses after splenectomy. This provides novel mechanistic insight into the intersection of metabolic and neuroimmune pathways in PND pathogenesis.

Methods and Experimental Design Insights

The study employed a well-characterized rodent model using 18-month-old male Sprague Dawley rats, which is relevant for modeling age-associated cognitive vulnerability. Animals were divided into six groups: sham surgery control, sham + adiponectin, PND (splenectomy), PND + adiponectin, PND + TAK-242 (a selective TLR4 inhibitor), and PND + adiponectin + LPS (to activate TLR4). Adiponectin was administered intragastrically at 10 μg/kg/day for 20 days prior to splenectomy. Cognitive function was evaluated using the Morris water maze (MWM) test, while hippocampal neuroinflammation, oxidative stress, and pathway activation were assessed by immunohistochemistry, western blotting, and ELISA for markers such as IBA1, TNF-α, IL-1β, IL-6, MDA, SOD, caspase 3, and components of the TLR4/MyD88/NF-κB pathway.

Protocol Parameters

• Adiponectin pretreatment: 10 μg/kg/day, administered intragastrically for 20 consecutive days before splenectomy.
• TAK-242 administration: 3 mg/kg, intraperitoneally, for TLR4 pathway inhibition.
• LPS challenge: 2 mg/kg, intraperitoneally, to activate TLR4 and test pathway specificity.
• Cognitive assessment: Performed via Morris water maze, evaluating spatial learning and memory post-surgery.
• Inflammatory and oxidative markers: Analyzed by immunohistochemistry, western blotting, and ELISA on hippocampal tissue.

Core Findings and Why They Matter

Treatment with adiponectin significantly improved spatial learning and memory performance in aged rats subjected to splenectomy, as measured by the MWM test. Mechanistically, adiponectin suppressed activation of the TLR4/MyD88/NF-κB p65 pathway in the hippocampus, leading to reduced expression of proinflammatory cytokines (TNF-α, IL-1β, IL-6) and markers of microglial activation (IBA1). Concurrently, adiponectin decreased oxidative damage, as indicated by lower malondialdehyde (MDA) levels and caspase 3-mediated apoptosis, while restoring antioxidant enzyme activity (SOD).

Pharmacological inhibition of TLR4 with TAK-242 recapitulated the effects of adiponectin, supporting the role of this pathway in mediating neuroinflammation and cognitive decline post-surgery. Conversely, TLR4 activation with LPS abolished the benefits of adiponectin, further validating pathway specificity. These results underscore the importance of TLR4/MyD88/NF-κB signaling in PND and position adiponectin as a promising modulator of neuroimmune responses following peripheral trauma.

Comparison with Existing Internal Articles

Several internal analyses have explored the broader landscape of neuroimmune signaling and cardiovascular peptides in translational research. For example, "Atrial Natriuretic Peptide (ANP), rat: Unraveling Its Intersections" and "Atrial Natriuretic Peptide (ANP): Innovations in Rat Cardiovascular Research" discuss the roles of ANP peptide hormone in blood pressure homeostasis, natriuresis, and, notably, its emerging relevance in neuroimmune modulation. While the present reference study focuses on adiponectin, these internal resources emphasize how peptides such as ANP also participate in neuroimmune cross-talk—particularly via regulation of inflammatory and oxidative stress pathways in the cardiovascular and central nervous systems. This convergence supports the growing recognition of peptide hormones as critical tools in both cardiovascular disease research and natriuresis mechanism study, as well as in models of neuroinflammatory disorders.

Limitations and Transferability

Despite robust mechanistic data, several limitations merit attention. The study utilized only aged male rats, and thus sex- and species-specific responses remain to be validated. The experimental design relied on pretreatment, which models prophylactic rather than therapeutic intervention; the efficacy of post-injury adiponectin administration is unknown. Furthermore, while the TLR4/MyD88/NF-κB pathway was convincingly implicated, other parallel or downstream pathways could contribute to observed effects. Translating these findings to human PND will require careful consideration of dosing, timing, and the complex interplay of systemic and central immune responses.

Research Support Resources

For researchers interested in investigating neuroimmune signaling, oxidative stress, or blood pressure homeostasis in rodent models, high-purity peptides such as Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat (SKU A1009) from APExBIO provide a validated platform for cardiovascular research peptide workflows. ANP shares mechanistic intersections with adiponectin in the regulation of vascular tone, natriuresis, and inflammation, as highlighted in internal reviews. Incorporating such research-grade peptides can enhance reproducibility and mechanistic depth in studies targeting neuroimmune and metabolic pathways.